Fulcrum Therapeutics (FULC)’s Stunning Trial Results Could Make it the Next Biotech Breakout!
Fulcrum Therapeutics Inc. (NASDAQ:FULC) is a clinical-stage biopharmaceutical company dedicated to developing small-molecule therapies that target the root…